Blausiegel Laboratory

Blau Farmacêutica, originally founded as Blausiegel, is a leading Brazilian pharmaceutical company specializing in high-complexity institutional and hospital medications. The company focuses on therapeutic areas such as oncology, nephrology, hematology, and infectious diseases, providing a wide range of injectable drugs and biological products. Blau operates several state-of-the-art manufacturing facilities in Brazil and has a dedicated biotechnology division that produces recombinant proteins and develops biosimilars. With a significant commercial footprint across Latin America, the company is a key regional player in the production of essential therapies like erythropoietin and filgrastim. Blau is publicly traded on the Brazilian stock exchange and continues to expand its portfolio through both internal R&D and strategic acquisitions.